Results 121 to 130 of about 148,737 (346)

Enterocyte function in progressive systemic sclerosis as estimated by the deconjugation of pteroyltriglutamate to folic acid. [PDF]

, 1987
Jakob Hendel, Jakob Hendel, I Joergensen
openalex   +1 more source

Progressive Systemic Sclerosis and Polymyositis [PDF]

Proceedings of the Royal Society of Medicine, 1976
A M Silas, A G White
openaire   +3 more sources

Mucosal‐Associated Invariant T Cells in Rheumatic Diseases

Arthritis &Rheumatology, EarlyView.
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor and restriction by the major histocompatibility complex class I–related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines.
Manon Lesturgie‐Talarek, Virginie Gonzalez, Lucie Beaudoin, Noémie Sénot, Corinne Miceli‐Richard, Yannick Allanore, Agnès Lehuen, Jerôme Avouac   +7 more
wiley   +1 more source

Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis

International Journal of General Medicine, 2022
Jiangfan Yu,1 Rui Tang,2 Ke Ding3 1Department of Dermatology, Second Xiangya Hospital of Central South University, Changsha, 410011, People’s Republic of China; 2Department of Rheumatology and Immunology, Second Xiangya Hospital of Central South ...
Yu J, Tang R, Ding K
doaj  

Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective We used data from the placebo arm of the Safety and Efficacy of Nintedanib in Systemic Sclerosis (SENSCIS) trial to determine the prognostic/predictive significance of peripheral blood cell (PBC) transcript modules for the course of forced vital capacity (FVC) in patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD ...
Shervin Assassi, Christopher P. Denton, Matthias Zwick, Ramona Schmid, Carina Ittrich, Tobias Litzenburger, Sudha Visvanathan   +6 more
wiley   +1 more source

Scleroderma (progressive systemic sclerosis) [PDF]

, 1981

openalex   +1 more source

OP0158 COHORT ENRICHMENT STRATEGIES FOR PROGRESSIVE INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS FROM EUSTAR [PDF]

, 2022
A. M. Hoffmann-Vold, Cathrine Brunborg, Paolo Airó, L. P. Ananyeva, L. Czirják, S. Guiducci, É. Hachulla, Ke Li, C. Mihai, G. Riemekasten, P. Sfikakis, Gabriele Valentini, Otylia Kowal‐Bielecka, Yannick Allanore, Oliver Distler   +14 more
openalex   +1 more source

The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis–Associated Interstitial Lung Disease [PDF]

, 2023
María Martín-López, Patrícia Carreira   +1 more
openalex   +1 more source

Rehabilitation interventions delivered via telehealth to support self‐management of rheumatic and musculoskeletal disease: A scoping review

Arthritis &Rheumatology, Accepted Article.
Objective To identify and summarize existing telerehabilitation interventions for people living with RMDs, including the rehabilitation components, the technology used, the type of health care professional (HCP) interaction, and how the effectiveness is evaluated.
Thomas A Ingram, Rosemarie Barnett, Nuzhat Shakaib, Simon Jones, Raj Sengupta, Peter C Rouse   +5 more
wiley   +1 more source

AB0886 PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE [PDF]

, 2023
Giovanna Cuomo, C. Di Vico, D. Perretta, C. Iandoli, Rebecca Ciaburri, Paola Adamo   +5 more
openalex   +1 more source